New drug studied to prevent dangerous drops in blood pressure during C-Sections
NCT ID NCT05264870
First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 33 times
Summary
This study looked at using norepinephrine to treat low blood pressure in women having a C-section under spinal anesthesia. The goal was to see how well it works and how it affects both mother and newborn. Only 11 people took part, and the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antwerp University Hospital
Edegem, 2650, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
norepinephrine
What this could lead to
If it works, this could point toward a better way to manage blood pressure during C-sections, reducing risks for mothers and babies.
What could go wrong
This is a very small, terminated Phase 4 trial with only 11 participants, so results may not be reliable or generalizable. Norepinephrine may also have side effects.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.